Community curated by people like you

Generic drugs stories

Sep 8, 2026

Sandoz CEO warns Trump generic drug tariffs would raise costs for American patients

The CEO of Swiss pharmaceutical company Sandoz cautioned that President Donald Trump's threatened tariffs on generic drugs would ultimately be paid by American patients, as manufacturers could pass increased costs onto consumers.

Sep 8, 2026·1 source

00

Top claims

▪Sandoz announced on September 8, 2026, its goal to expand its biosimilar portfolio to more than 100 products by 2040, up from 13 products currently.
▪Sandoz announced a new initiative on September 8, 2026, to capitalize on an upcoming wave of patent expirations and loss of exclusivity for branded medicines, particularly in immunology and oncology.
▪Sandoz secured approval in Brazil in 2026 to launch generic semaglutide, the active ingredient in Novo Nordisk's Ozempic and Wegovy, and expects Canadian approval soon.

People involved

Subtopics

Tariffs & trade wars Healthcare costs U.S. trade policy Pharmaceutical Industry

Related timelines

AI Data Center Gold Rush

Congress

Cyclosporiasis outbreak

Payments

Russia-Ukraine war